DK1003486T3 - Farmaceutisk præparat indeholdende et bruse-syre-basepar - Google Patents

Farmaceutisk præparat indeholdende et bruse-syre-basepar

Info

Publication number
DK1003486T3
DK1003486T3 DK98941377T DK98941377T DK1003486T3 DK 1003486 T3 DK1003486 T3 DK 1003486T3 DK 98941377 T DK98941377 T DK 98941377T DK 98941377 T DK98941377 T DK 98941377T DK 1003486 T3 DK1003486 T3 DK 1003486T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
brace
composition containing
base pair
acid base
Prior art date
Application number
DK98941377T
Other languages
Danish (da)
English (en)
Inventor
Paolo Chiesi
Paolo Ventura
Rosa Mezzadri
Gaetano Brambilla
Daniela Acerbi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of DK1003486T3 publication Critical patent/DK1003486T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DK98941377T 1997-07-23 1998-07-23 Farmaceutisk præparat indeholdende et bruse-syre-basepar DK1003486T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI001746A IT1293764B1 (it) 1997-07-23 1997-07-23 Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
PCT/EP1998/004517 WO1999004765A2 (en) 1997-07-23 1998-07-23 Pharmaceutical compositions containing an effervescent acid-base couple

Publications (1)

Publication Number Publication Date
DK1003486T3 true DK1003486T3 (da) 2003-05-19

Family

ID=11377613

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98941377T DK1003486T3 (da) 1997-07-23 1998-07-23 Farmaceutisk præparat indeholdende et bruse-syre-basepar

Country Status (27)

Country Link
US (1) US6284272B1 (cs)
EP (1) EP1003486B1 (cs)
JP (1) JP4801255B2 (cs)
KR (1) KR100528141B1 (cs)
CN (1) CN1138535C (cs)
AT (1) ATE232092T1 (cs)
AU (1) AU743186B2 (cs)
BG (1) BG64074B1 (cs)
BR (1) BR9801335B1 (cs)
CZ (1) CZ296221B6 (cs)
DE (1) DE69811236T2 (cs)
DK (1) DK1003486T3 (cs)
EA (1) EA002608B1 (cs)
ES (1) ES2191960T3 (cs)
HK (1) HK1029525A1 (cs)
HU (1) HU226115B1 (cs)
IL (1) IL134166A (cs)
IT (1) IT1293764B1 (cs)
NO (1) NO326639B1 (cs)
NZ (1) NZ502479A (cs)
OA (1) OA10999A (cs)
PL (1) PL199164B1 (cs)
PT (1) PT1003486E (cs)
SI (1) SI1003486T1 (cs)
SK (1) SK284551B6 (cs)
TR (1) TR199900675T1 (cs)
WO (1) WO1999004765A2 (cs)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151768A1 (en) * 1997-07-23 2004-08-05 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple
FR2786395A1 (fr) * 1998-12-01 2000-06-02 Virbac Sa Compositions seches solubles en presence d'eau et evitant la reaction de maillard a l'etat sec, leur preparation et leurs applications
WO2001001992A1 (en) * 1999-07-02 2001-01-11 Sca Lohnherstellungs Ag A solid formulation of glucosamine sulphate
AP2002002410A0 (en) * 1999-08-04 2002-03-31 Ranbaxy Laboratories Ltd Hydrodynamically Balancing Oral Drug Delivery System
IN190018B (cs) * 1999-09-28 2003-05-31 Panacea Biotec Ltd
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
AU2001285011A1 (en) * 2000-08-18 2002-03-04 Pharmacia Corporation Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
US6531153B2 (en) 2001-05-29 2003-03-11 Drugtech Corporation Composition with sustained release of levodopa and carbidopa
US6762153B2 (en) * 2001-10-18 2004-07-13 Rohm And Haas Company Delivery system for cyclopropenes
US20030091627A1 (en) * 2001-10-31 2003-05-15 Vinay Sharma Rate-controlled delivery of macrolides
KR100456273B1 (ko) 2001-11-16 2004-11-10 김용년 산과 반응하여 일정 속도로 이산화탄소를 발생시킬 수있는 고상 제제 및 그의 제조 방법
US7488496B2 (en) * 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
WO2003075884A1 (en) 2002-03-06 2003-09-18 Lifizz, Inc. Effervescent compositions comprising bisphosphonates and methods related thereto
BG730Y1 (bg) * 2003-03-20 2005-04-30 Владимир НАЙДЕНОВ Ефервесцентна лекарствена форма
CN100445263C (zh) * 2003-04-24 2008-12-24 四川大学 甘氨酸钠碳酸盐的微波合成方法
FR2876911B1 (fr) * 2004-10-21 2007-04-13 Pierre Fabre Medicament Sa Complexe comprenant du piroxicam, une cyclodextrine et de l'arginine
EP1729813B1 (fr) 2004-04-01 2011-04-06 Pierre Fabre Medicament Complexes d'inclusions comprenant du piroxicam, une cyclodextrine et l'arginine
EP1750677B1 (en) * 2004-05-28 2017-02-01 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
AU2006261893A1 (en) * 2005-06-23 2007-01-04 Combinatorx, Incorporated Improved dosage forms for movement disorder treatment
CN100341488C (zh) * 2005-11-22 2007-10-10 瑞普（保定）生物药业有限公司 一种饮水免疫泡腾片及其制备方法
CA2629904C (en) * 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US20080131492A1 (en) * 2006-06-23 2008-06-05 Spherics, Inc. Dosage forms for movement disorder treatment
EP2063867A2 (en) * 2006-12-22 2009-06-03 Combinatorx, Incorporated Pharmaceutical compositions for treatment of parkinson's disease and related disorders
MX2009011973A (es) * 2007-05-08 2009-12-10 Hercules Inc Formulacion robusta de tabletas que se desintegran con rapidez.
CN101910113A (zh) 2007-12-28 2010-12-08 怡百克制药公司 左旋多巴控释制剂及其用途
WO2010011522A1 (en) 2008-07-21 2010-01-28 Albemarle Corporation High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
EP3513660A1 (en) * 2010-03-13 2019-07-24 Eastpond Laboratories Limited Fat-binding compositions
CN101836951B (zh) * 2010-05-20 2013-06-05 山东达因海洋生物制药股份有限公司 一种含盐酸氨溴索的口服溶液及其制备方法
CN102322123B (zh) * 2011-06-30 2013-09-18 德清艺玛工艺装饰有限公司 一种仿大理石泡沫装饰材料
CN102398378A (zh) * 2011-11-03 2012-04-04 北京华禧联合科技发展有限公司 镀铬冲模在硫酸氢氯吡格雷片制备过程中的应用
EP2931261A1 (en) * 2012-12-14 2015-10-21 SI Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
CA2926082C (en) 2013-10-07 2022-06-14 Impax Laboratories, Inc. Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
EP2870961B1 (en) * 2013-11-06 2018-07-18 Sanovel Ilac Sanayi ve Ticaret A.S. Effervescent formulations of pramipexole
US11844860B2 (en) 2018-03-02 2023-12-19 Chiesi Farmaceutici S.P.A. Pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
ATE76747T1 (de) * 1986-06-10 1992-06-15 Chiesi Farma Spa Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
CH675537A5 (cs) * 1988-03-25 1990-10-15 Ciba Geigy Ag
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
DE69102900T3 (de) * 1990-02-14 1998-04-09 Takeda Chemical Industries Ltd Brausemischung, deren Herstellung sowie Verwendung.
US5252341A (en) * 1990-07-16 1993-10-12 Degussa Aktiengesellschaft Tablets and granulates containing mesna as active substance
JP2910425B2 (ja) * 1992-06-17 1999-06-23 和光純薬工業株式会社 発泡性錠剤の新規な製造方法
JP3170139B2 (ja) * 1994-04-08 2001-05-28 エスエス製薬株式会社 発泡性錠剤
FR2733420B1 (fr) * 1995-04-28 1997-06-27 Sep Tarral Preparations pectiques utilisables comme support de medicament
WO1997044017A1 (en) * 1996-05-17 1997-11-27 Merck & Co., Inc. Effervescent bisphosphonate formulation

Also Published As

Publication number Publication date
AU8977798A (en) 1999-02-16
ES2191960T3 (es) 2003-09-16
NO326639B1 (no) 2009-01-26
JP4801255B2 (ja) 2011-10-26
SI1003486T1 (en) 2003-08-31
NO991376L (no) 1999-05-25
WO1999004765A2 (en) 1999-02-04
BG64074B1 (bg) 2003-12-31
PL199164B1 (pl) 2008-08-29
HK1029525A1 (en) 2001-04-06
PT1003486E (pt) 2003-06-30
ITMI971746A1 (it) 1999-01-23
BR9801335B1 (pt) 2010-09-21
OA10999A (en) 2001-11-07
CZ296221B6 (cs) 2006-02-15
IL134166A0 (en) 2001-04-30
EA002608B1 (ru) 2002-06-27
CN1267215A (zh) 2000-09-20
IT1293764B1 (it) 1999-03-10
AU743186B2 (en) 2002-01-17
BR9801335A (pt) 1999-05-04
HUP0003897A2 (hu) 2001-08-28
KR100528141B1 (ko) 2005-11-15
BG103253A (en) 1999-09-30
HUP0003897A3 (en) 2006-06-28
WO1999004765A3 (en) 1999-06-10
EA200000062A1 (ru) 2000-10-30
KR20010022140A (ko) 2001-03-15
SK284551B6 (sk) 2005-06-02
DE69811236T2 (de) 2003-10-30
ATE232092T1 (de) 2003-02-15
DE69811236D1 (de) 2003-03-13
JP2001510789A (ja) 2001-08-07
SK922000A3 (en) 2000-07-11
US6284272B1 (en) 2001-09-04
PL338502A1 (en) 2000-11-06
EP1003486A2 (en) 2000-05-31
HU226115B1 (en) 2008-04-28
NO991376D0 (no) 1999-03-22
EP1003486B1 (en) 2003-02-05
CN1138535C (zh) 2004-02-18
IL134166A (en) 2005-08-31
NZ502479A (en) 2002-02-01
CZ2000255A3 (cs) 2000-07-12
TR199900675T1 (xx) 1999-11-22

Similar Documents

Publication Publication Date Title
DK1003486T3 (da) Farmaceutisk præparat indeholdende et bruse-syre-basepar
DE69626117D1 (de) Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung von reversiblen protonpumpen-inhibitoren
TWI235068B (en) Sustained-release pharmaceutical composition
IS4329A (is) Fjöleiningaskammtar í töfluformi sem innihalda prótónupumpublokkara
UA66847C2 (uk) Тверда швидкорозчинна композиція селегіліну та спосіб її одержання
MY106412A (en) Pharmaceutical compositions.
LV11984A (lv) Farmaceitiska kompozicija putojosa dzeriena pagatavosanai
ID28510A (id) Formulasi oral yang baru untuk agonis atau antagonis 5-ht4
CA2297673A1 (en) Pharmaceutical compositions containing an effervescent acid-base couple
EP0948961A3 (de) Calciumhaltige Brausetablette mit einem Antihistaminikum als Wirkstoff
CA2225628A1 (en) Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors